PT  - JOURNAL ARTICLE
AU  - Hidefumi Nishimori
AU  - Roger Tabah
AU  - Marc Hickeson
AU  - Jacques How
TI  - Incidental thyroid “PETomas”: clinical significance and novel description of the self-resolving variant of focal FDG-PET thyroid uptake
AID  - 10.1503/cjs.023209
DP  - 2011 Apr 01
TA  - Canadian Journal of Surgery
PG  - 83--88
VI  - 54
IP  - 2
4099  - http://canjsurg.ca/content/54/2/83.short
4100  - http://canjsurg.ca/content/54/2/83.full
SO  - CAN J SURG2011 Apr 01; 54
AB  - Background: Recent series of incidental thyroid activity on fluorodeoxyglucose positron emission tomography (FDG-PET) in patients evaluated for nonthyroidal malignancy, which we refer to as a “PEToma,” have suggested that such lesions are associated with a significant incidence of primary thyroid cancer.Methods: We retrospectively reviewed 6457 FDG-PET scans performed on 4726 patients from May 2004 to March 2007. We reviewed the cases of patients whose PET or computed tomography (CT) radiology reports described PET uptake within the thyroid to identify incidence and malignant potential of PETomas and evaluate their clinical and histopathologic features.Results: We found that 160 patients (3.4%) had incidental, abnormal FDG uptake in the thyroid gland, 103 of whom had focal uptake (the PEToma group). Of these patients, 50 (48%) underwent further investigations, including ultrasonography in 48, fine-needle aspiration cytology in 38 and computed tomography in 3. Ten patients underwent surgery, and papillary thyroid cancer was identified in 9. The remaining 53 patients with PETomas underwent no further investigation. Interestingly, 5 patients who had focal uptake within the thyroid showed either spontaneous resolution on repeat FDG-PET (self-resolving) or no focal lesion on subsequent ultrasonography (false-positive).Conclusion: The incidence of papillary thyroid cancer in the present series is similar to that in the literature. Although some patients will show self-resolving or false-positive focal thyroid uptake on FDG-PET, we believe that, if the patient’s clinical status permits, the evaluation of patients with incidental thyroid PEToma should include ultrasonographic confirmation and fine-needle aspiration cytology.